Talk to your health care provider about the best way to use rescue seizure medicine. Make sure you have a specific plan on when to use it and when not to.
Are you having seizures? Explore all options.
The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.
Create your epilepsy team.
Join our mailing list to stay to date about programs, events, and news about epilepsy.
Some people don’t like the idea of using a medicine rectally, or their doctor may feel that an oral medicine is better for them. You may be asked to take or give a medicine in one of three ways.
8301 Professional Place East, Suite 200, Landover, MD 20785| 1.800.332.1000.
Always here for you. Join the community.
In these situations, talk to your doctor about rectal forms of the medicine such as Diastat. However, it may be hard to give medicines this way to an infant or young child, a person who is too sleepy or not able to cooperate, a person who can not keep the medicine in their mouth (for example someone who drools or has vomited), or a person who is having too many seizures. Taking the pills orally is usually easier for most people.
People who are prescribed these medicines or who are asked to give them to someone else (such as their child) should receive one on one teaching from a doctor or nurse. Some forms of injections and nasal sprays are being developed and tested. The following information will help people understand important facts about giving and using rescue medicines that are meant to be taken orally or sublingually (which means under the tongue). When used outside of a hospital setting, they are usually given by mouth. Some fast-acting medicines, such as diazepam or lorazepam, can be used 'as needed' to stop seizures.
Epilepsy Foundation of America, d/b/a Epilepsy Foundation, is a non-profit organization with a 501(3) tax-exempt status. 2018.
Help find the answers now.
Eur J Paediatr Neurol. 2018 Jan;22(1):56-63. doi: 10.1016/j.ejpn.2017.07.017. Epub 2017 Aug 2. Effect of rescue medication on seizure duration in.
Characterize the real-world management of and outcomes for children with epilepsy receiving rescue medication for prolonged acute convulsive seizures (PACS) in the community.
National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA. National Center for Biotechnology Information, U.S.
Investigators provided clinical assessments and parents/guardians completed questionnaires. Statistical tests were post hoc; p values are descriptive.
Characterize the real-world management of and outcomes for children with epilepsy receiving rescue medication for prolonged acute convulsive seizures.
Rescue medication use was significantly associated with average seizures lasting <5 min (χ2 = 58.8; p < 0.0001). Most patients experienced PACS despite regular anti-epilepsy medication. According to parents, the average duration of their child's seizures without rescue medication was <5 min in 35.7% of patients, 5–<20 min in 42.6%, and ≥20 min in 21.7% ( n = 258); with rescue medication seizure duration was <5 min in 69.4% of patients, 5–<20 min in 25.6%, and ≥20 min in 5.0%.
For all children in the EPIC area who had been prescribed epilepsy rescue medication for use in the community a questionnaire was completed by the clinician.
A questionnaire was also completed by the carers about their experience of the use of rescue medication in their child. For all children in the EPIC area who had been prescribed epilepsy rescue medication for use in the community a questionnaire was completed by the clinician for each child relating to rescue medication prescribed, the epilepsy syndrome and seizure type.
It was felt by families to be the safest (least side effects reported) and the most effective (most likely to terminate seizures) of the rescue medications.
Midazolam was prescribed buccally if excessive head movement accompanied seizures. The protocol reverted to the usual rescue medication if there was no.
ScienceDirect is a registered trademark of Elsevier B.V. or its licensors or contributors. 2018 Elsevier B.V.
This field trial was designed to test the feasibility of the use of intranasal midazolam as an alternative to rectal diazepam in a cohort of patients with severe epilepsy who require rescue medication as part of their treatment.